Axsome Therapeutics nimmt an vier Investorenkonferenzen teil
- Axsome Therapeutics nimmt am 9. November 2026 an der Guggenheim Healthcare Innovation Conference in Boston mit einem Kamingespräch teil.
- Investorengespräche bei der Wolfe Research Healthcare Conference am 10. November 2026 in New York vorgesehen.
- Beim Truist BioPharma Symposium am 12. November 2026 in New York stehen ebenfalls Investorengespräche an.
- Ein weiteres Kamingespräch folgt am 16. November 2026 bei der UBS Global Biopharma Conference in London.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Axsome Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611030700PRIMZONECNPR____9868674) on November 03, 2026, and is solely responsible for the information contained therein.